Prognos Health and Mirador Analytics Form Strategic Partnership to Streamline Expert Determination for Patient-Level Data
New York, NY (June 22, 2021) — Prognos Health, a leading healthcare analytics platform company, and Mirador Analytics, the leading HIPAA expert determination provider, today announced a strategic partnership to provide Prognos clients with a more streamlined end-to-end HIPAA certification process that reduces risk.
“At Prognos we are committed to maintaining the highest level of privacy and security for our data and our technology. This partnership with Mirador is an extension of that promise,” said Jason Bhan, MD, co-founder and chief medical officer, Prognos Health. “By working with Mirador to integrate their leading expert determination services and support into our prognosFACTORⓇ platform, our clients can be assured that our analytics or data purchase options on our marketplace are fully de-identified and compliant with HIPAA privacy regulations.”
By partnering with Mirador Analytics, Prognos is able to utilize a suite of programmatic tests to assess the risk of re-identification in healthcare datasets, tools to determine dataset compliance, and have access to an automated approach to removing elements that present any potential risk of re-identification.
“At Mirador, we understand that organizations need more agile access and greater value from healthcare data and so we help them to innovate and improve care quality without compromising compliance and patient confidentiality. We’re excited to partner with Prognos because they have something unique – the ability to link lab test result data with other more traditional and emerging datasets at scale,” shared Jamie Blackport, founder and chief executive officer, Mirador Analytics. “We look forward to expanding our partnership to accelerate our expert-led risk monitoring automation processes within the Prognos environment.”
To continue improving scalability, Prognos Health and Mirador Analytics seek to further develop the partnership in the future to provide an even faster, more automated process using a SaaS model embedded within Prognos Health’s prognosFACTOR platform.
Winners of COVID-19 Research Accelerator Grants Announced
Congratulations to the 15 winners of the first Research Accelerator grants, funded by the Bill & Melinda Gates Foundation! We are very proud to support this initiative, and we look forward to seeing the research outputs.
The Accelerator Program has received hundreds of applications from every corner of the globe. The awardees will find evidence for policies that mitigate the effects of the current pandemic and strengthen future disaster preparedness. The projects will leverage the COVID-19 Research Database with more than 250 million unique patients and 85 billion records. The Database is the largest HIPAA-compliant, de-identified, and limited patient-level data sets of real-world data. Read more: Winners of COVID-19 Research Accelerator Grants Announced (globenewswire.com)
Life after the COVID-19 outbreak
Our team has celebrated Mirador Day recently with much fun and outdoor activities which they kindly shared with us. They went cycling, camping, and walking; they visited their old universities and friends. Others enjoyed some lovely family time with their kids, both indoors and outdoors.
Our team is the heart of our business; they are our superstars. We are dedicated to protecting them from the risk of infection and helping them stay physically and mentally healthy.
Author: Eszter Vuity